Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Veterinary Vaccine was estimated at US$ 10806 million in the year 2022, is projected to reach a revised size of US$ 17260 million by 2029, growing at a CAGR of 6.94% during the forecast period 2023-2029.
North American market for Veterinary Vaccine was valued at $ 3870 million in 2022, will reach $ 5908 million by 2029, at a CAGR of 6.29 % during the forecast period of 2023 through 2029.
Asia-Pacific market for Veterinary Vaccine was valued at $ 3240 million in 2022, will reach $ 5565 million by 2029, at a CAGR of 7.98 % during the forecast period of 2023 through 2029.
Europe market for Veterinary Vaccine was valued at $ 2426 million in 2022, will reach $ 3708 million by 2029, at a CAGR of 6.3 % during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Veterinary Vaccine segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- RVSRI
- Medion
Segment by Type
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
Segment by Application
- Farm Animal
- Companion Animal
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- South America
- Brazil
- Middle East & Africa
- Turkey
- Saudi Arabia
- Egypt
- South Africa
Core Chapters
- Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter Two: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
- Chapter Three: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
- Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
- Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter Twelve: Analysis of sales channel, distributors and customers.
- Chapter Thirteen: Research Findings and Conclusion.
Table of Contents
1 Veterinary Vaccine Market Overview
- 1.1 Veterinary Vaccine Product Overview
- 1.2 Veterinary Vaccine Market by Type
- 1.2.1 Live Attenuated Vaccines
- 1.2.2 Inactivated Vaccines
- 1.3 Global Veterinary Vaccine Market Size by Type
- 1.3.1 Global Veterinary Vaccine Market Size Overview by Type (2018-2029)
- 1.3.2 Global Veterinary Vaccine Historic Market Size Review by Type (2018-2023)
- 1.3.3 Global Veterinary Vaccine Forecasted Market Size by Type (2024-2029)
- 1.4 Key Regions Market Size by Type
- 1.4.1 North America Veterinary Vaccine Sales Breakdown by Type (2018-2023)
- 1.4.2 Europe Veterinary Vaccine Sales Breakdown by Type (2018-2023)
- 1.4.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2018-2023)
- 1.4.4 South America Veterinary Vaccine Sales Breakdown by Type (2018-2023)
- 1.4.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2018-2023)
2 Veterinary Vaccine Market Competition by Company
- 2.1 Global Top Players by Veterinary Vaccine Sales (2018-2023)
- 2.2 Global Top Players by Veterinary Vaccine Revenue (2019-2023)
- 2.3 Global Top Players by Veterinary Vaccine Price (2019-2023)
- 2.4 Global Top Manufacturers Veterinary Vaccine Manufacturing Base Distribution, Sales Area, Product Type
- 2.5 Veterinary Vaccine Market Competitive Situation and Trends
- 2.5.1 Veterinary Vaccine Market Concentration Rate (2019-2023)
- 2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Revenue in 2022
- 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2022)
- 2.7 Founded Date of Key Veterinary Vaccine Manufacturers
- 2.8 Key Manufacturers Veterinary Vaccine Product Offered
- 2.9 Mergers & Acquisitions, Expansion
3 Veterinary Vaccine Status and Outlook by Region
- 3.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
- 3.2 Global Veterinary Vaccine Historic Market Size by Region
- 3.2.1 Global Veterinary Vaccine Sales in Volume by Region (2018-2023)
- 3.2.2 Global Veterinary Vaccine Sales in Value by Region (2018-2023)
- 3.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2018-2023)
- 3.3 Global Veterinary Vaccine Forecasted Market Size by Region
- 3.3.1 Global Veterinary Vaccine Sales in Volume by Region (2024-2029)
- 3.3.2 Global Veterinary Vaccine Sales in Value by Region (2024-2029)
- 3.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Veterinary Vaccine by Application
- 4.1 Veterinary Vaccine Market by Application
- 4.1.1 Farm Animal
- 4.1.2 Companion Animal
- 4.2 Global Veterinary Vaccine Market Size by Application
- 4.2.1 Global Veterinary Vaccine Market Size Overview by Application (2018-2029)
- 4.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2018-2023)
- 4.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2024-2029)
- 4.3 Key Regions Market Size by Application
- 4.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2018-2023)
- 4.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2018-2023)
- 4.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2018-2023)
- 4.3.4 South America Veterinary Vaccine Sales Breakdown by Application (2018-2023)
- 4.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2018-2023)
5 North America Veterinary Vaccine by Country
- 5.1 North America Veterinary Vaccine Historic Market Size by Country
- 5.1.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 5.1.2 North America Veterinary Vaccine Sales in Volume by Country (2018-2023)
- 5.1.3 North America Veterinary Vaccine Sales in Value by Country (2018-2023)
- 5.2 North America Veterinary Vaccine Forecasted Market Size by Country
- 5.2.1 North America Veterinary Vaccine Sales in Volume by Country (2024-2029)
- 5.2.2 North America Veterinary Vaccine Sales in Value by Country (2024-2029)
6 Europe Veterinary Vaccine by Country
- 6.1 Europe Veterinary Vaccine Historic Market Size by Country
- 6.1.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 6.1.2 Europe Veterinary Vaccine Sales in Volume by Country (2018-2023)
- 6.1.3 Europe Veterinary Vaccine Sales in Value by Country (2018-2023)
- 6.2 Europe Veterinary Vaccine Forecasted Market Size by Country
- 6.2.1 Europe Veterinary Vaccine Sales in Volume by Country (2024-2029)
- 6.2.2 Europe Veterinary Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Veterinary Vaccine by Region
- 7.1 Asia-Pacific Veterinary Vaccine Historic Market Size by Region
- 7.1.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
- 7.1.2 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2018-2023)
- 7.1.3 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2018-2023)
- 7.2 Asia-Pacific Veterinary Vaccine Forecasted Market Size by Region
- 7.2.1 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2024-2029)
- 7.2.2 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2024-2029)
8 South America Veterinary Vaccine by Country
- 8.1 South America Veterinary Vaccine Historic Market Size by Country
- 8.1.1 South America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 8.1.2 South America Veterinary Vaccine Sales in Volume by Country (2018-2023)
- 8.1.3 South America Veterinary Vaccine Sales in Value by Country (2018-2023)
- 8.2 South America Veterinary Vaccine Forecasted Market Size by Country
- 8.2.1 South America Veterinary Vaccine Sales in Volume by Country (2024-2029)
- 8.2.2 South America Veterinary Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Veterinary Vaccine by Country
- 9.1 Middle East and Africa Veterinary Vaccine Historic Market Size by Country
- 9.1.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 9.1.2 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2018-2023)
- 9.1.3 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2018-2023)
- 9.2 Middle East and Africa Veterinary Vaccine Forecasted Market Size by Country
- 9.2.1 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2024-2029)
- 9.2.2 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
- 10.1 Merck
- 10.1.1 Company Profile
- 10.1.2 Product Information
- 10.1.3 Sales, Price and Revenue
- 10.2 Zoetis
- 10.2.1 Company Profile
- 10.2.2 Product Information
- 10.2.3 Sales, Price and Revenue
- 10.3 Boehringer Ingelheim
- 10.3.1 Company Profile
- 10.3.2 Product Information
- 10.3.3 Sales, Price and Revenue
- 10.4 Ceva
- 10.4.1 Company Profile
- 10.4.2 Product Information
- 10.4.3 Sales, Price and Revenue
- 10.5 CAHIC
- 10.5.1 Company Profile
- 10.5.2 Product Information
- 10.5.3 Sales, Price and Revenue
- 10.6 HVRI
- 10.6.1 Company Profile
- 10.6.2 Product Information
- 10.6.3 Sales, Price and Revenue
- 10.7 Ringpu Biology
- 10.7.1 Company Profile
- 10.7.2 Product Information
- 10.7.3 Sales, Price and Revenue
- 10.8 Yebio
- 10.8.1 Company Profile
- 10.8.2 Product Information
- 10.8.3 Sales, Price and Revenue
- 10.9 DHN
- 10.9.1 Company Profile
- 10.9.2 Product Information
- 10.9.3 Sales, Price and Revenue
- 10.10 WINSUN
- 10.10.1 Company Profile
- 10.10.2 Product Information
- 10.10.3 Sales, Price and Revenue
- 10.11 Elanco
- 10.11.1 Company Profile
- 10.11.2 Product Information
- 10.11.3 Sales, Price and Revenue
- 10.12 Virbac
- 10.12.1 Company Profile
- 10.12.2 Product Information
- 10.12.3 Sales, Price and Revenue
- 10.13 Jinyu Bio-Technology
- 10.13.1 Company Profile
- 10.13.2 Product Information
- 10.13.3 Sales, Price and Revenue
- 10.14 ChengDu Tecbond
- 10.14.1 Company Profile
- 10.14.2 Product Information
- 10.14.3 Sales, Price and Revenue
- 10.15 CAVAC
- 10.15.1 Company Profile
- 10.15.2 Product Information
- 10.15.3 Sales, Price and Revenue
- 10.16 Kyoto Biken Laboratories
- 10.16.1 Company Profile
- 10.16.2 Product Information
- 10.16.3 Sales, Price and Revenue
- 10.17 FATRO
- 10.17.1 Company Profile
- 10.17.2 Product Information
- 10.17.3 Sales, Price and Revenue
- 10.18 Vaksindo
- 10.18.1 Company Profile
- 10.18.2 Product Information
- 10.18.3 Sales, Price and Revenue
- 10.19 Bio-Labs
- 10.19.1 Company Profile
- 10.19.2 Product Information
- 10.19.3 Sales, Price and Revenue
- 10.20 Avimex Animal Health
- 10.20.1 Company Profile
- 10.20.2 Product Information
- 10.20.3 Sales, Price and Revenue
- 10.21 MEVAC
- 10.21.1 Company Profile
- 10.21.2 Product Information
- 10.21.3 Sales, Price and Revenue
- 10.22 Biovac
- 10.22.1 Company Profile
- 10.22.2 Product Information
- 10.22.3 Sales, Price and Revenue
- 10.23 Atafen
- 10.23.1 Company Profile
- 10.23.2 Product Information
- 10.23.3 Sales, Price and Revenue
- 10.24 Dyntec
- 10.24.1 Company Profile
- 10.24.2 Product Information
- 10.24.3 Sales, Price and Revenue
- 10.25 RVSRI
- 10.25.1 Company Profile
- 10.25.2 Product Information
- 10.25.3 Sales, Price and Revenue
- 10.26 Medion
- 10.26.1 Company Profile
- 10.26.2 Product Information
- 10.26.3 Sales, Price and Revenue
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
- 11.1 Veterinary Vaccine Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.2.1 Raw Materials
- 11.2.2 Labor Cost
- 11.2.3 Manufacturing Expenses
- 11.3 Veterinary Vaccine Industrial Chain Analysis
- 11.4 Veterinary Vaccine Market Dynamics
- 11.4.1 Veterinary Vaccine Industry Trends
- 11.4.2 Veterinary Vaccine Market Drivers
- 11.4.3 Veterinary Vaccine Market Challenges
- 11.4.4 Veterinary Vaccine Market Restraints
12 Marketing Strategy Analysis, Distributors
- 12.1 Sales Channel
- 12.2 Veterinary Vaccine Distributors
- 12.3 Veterinary Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
- 14.3 Disclaimer